top of page
Search

Operational Roadmap: Deploying FMTVDM and ITIRD at National Scale

  • Writer: Richard M Fleming, PhD, MD, JD
    Richard M Fleming, PhD, MD, JD
  • Oct 23
  • 2 min read

Updated: Oct 25

Government and Ministerial summary


A phased national deployment preserves measurement integrity and sovereignty while accelerating capability. The roadmap sequences readiness scoring, calibrated pilots, governance provisioning, scale‑up, and regional leadership steps so ministries can reliably achieve a measurable 5+ year head start in outcomes.


Phase 1 — Readiness and pre‑assessment


  • Inventory: scanners, staff, IT, and sample volumes.

  • Governance nomination: institutional PI, ministerial delegate, and technical champion.

  • Pre‑assessment deliverable: readiness score, gaps, estimated timeline, and pilot cohort suggestion.


Phase 2 — Pilot commissioning and calibration


  • Reference site selection: single calibrated scanner with phantom baselines.

  • Protocol lock: harmonized acquisition and reconstruction parameters.

  • ITIRD alignment: define ITIRD diagnostic thresholds, lab panels, and clinical decision pathways.

  • Training: mandatory certification for technologists, physicists, and clinicians.


Phase 3 — Validation, governance, and evidence generation


  • Cross‑site concordance: inter‑site comparisons and statistical validation.

  • ITIRD validation cohorts: confirm thresholds across demographics and comorbidities.

  • Governance board: change control, update approval, and ministerial reporting cadence.

  • Public summary reporting: independent validation publications and policy briefs.


Phase 4 — Scale and regional leadership


  • Cascade training: reference center mentors partner sites with calibrated kits.

  • Operational independence: on‑site data custody, escrowed keys, and local validation labs.

  • Regional hosting: offer training, trials, and validation studies to neighboring nations.


Pilot vignette (concise)


A country completed a 9‑month reference pilot, validated ITIRD thresholds across two partner sites, and scaled to five sites within 18 months—achieving inter‑site concordance >90% and a validation brief.


CTA and next steps


  • Primary CTA: Request an SNS pre‑assessment that includes FMTVDM calibration and ITIRD cohort design.

  • Secondary CTA: Determine operational checklist and pilot protocol template.


KPIs to track


  • Time to calibrated clinical use from procurement.

  • Inter‑site concordance percentage for core biomarkers.

  • Number of certified personnel and trained partner sites.

  • Publication/validation output count and time to public report.


Operational roadmap showing phased national deployment of FMTVDM and ITIRD: readiness → calibrated pilot → validation and governance → scale and regional leadership, with milestones and expected timelines.
Operational roadmap showing phased national deployment of FMTVDM and ITIRD: readiness → calibrated pilot → validation and governance → scale and regional leadership, with milestones and expected timelines.

 
 
 

Comments


EMAIL FMTVDM FRONTIER
CONSORTIUM
DIRECTLY

Screenshot 2025-09-07 at 1.47.45 PM.png

FMTVDM FRONTIER INQUIRY

Multi-line address
Drawing mode selected. Drawing requires a mouse or touchpad. For keyboard accessibility, select Type or Upload.

© 2025 by Richard M Fleming, PhD, MD, JD.

Director, FMTVDM FRONTIER Consortium

Powered and secured by Wix

bottom of page